Myla Lai - Sep 16, 2021 Form 3 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Myla Lai-Goldman, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Sep 16, 2021
Transactions value $
$0
Form type
3
Date filed
9/20/2021, 08:48 PM
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AKYA No securities are beneficially owned. 0 Sep 16, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 Power of Attorney